| Ticker |
Owner |
Relationship |
Date |
Transaction |
Cost  |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Apr 17 | Sale | 56.60 | 10,000 | 565,986 | 55,071 | Apr 18 05:13 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Mar 15 | Sale | 56.74 | 11,000 | 624,107 | 55,071 | Mar 16 06:17 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Feb 15 | Sale | 58.17 | 1,000 | 58,170 | 49,657 | Feb 16 05:56 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Feb 16 | Sale | 56.53 | 10,000 | 565,271 | 49,657 | Feb 16 05:56 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Jan 17 | Sale | 54.32 | 11,983 | 650,945 | 50,657 | Jan 18 05:06 PM |
|
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Jan 04 | Sale | 59.22 | 7,500 | 444,148 | 52,640 | Jan 06 06:28 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Jan 05 | Sale | 60.08 | 400 | 24,031 | 52,640 | Jan 06 06:28 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Jan 06 | Sale | 60.12 | 2,100 | 126,246 | 52,640 | Jan 06 06:28 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Dec 15 | Sale | 55.99 | 5,000 | 279,963 | 52,640 | Dec 15 07:00 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Dec 12 | Sale | 55.15 | 16,983 | 936,631 | 52,640 | Dec 13 06:04 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Sep 21 | Sale | 50.81 | 1,166 | 59,242 | 45,311 | Sep 22 05:01 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Sep 22 | Sale | 50.84 | 3,834 | 194,926 | 45,311 | Sep 22 05:01 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Sep 16 | Sale | 48.87 | 5,000 | 244,331 | 45,311 | Sep 19 05:21 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Sep 06 | Sale | 46.02 | 10,000 | 460,235 | 45,311 | Sep 07 05:31 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Jul 26 | Sale | 51.82 | 800 | 41,455 | 45,311 | Jul 28 05:06 PM |
|
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Jul 27 | Sale | 51.95 | 34,399 | 1,787,076 | 45,311 | Jul 28 05:06 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Apr 21 | Sale | 62.39 | 25,000 | 1,559,644 | 24,956 | Apr 23 05:12 PM |
| ALKS | Ehrich Elliot | EVP, R&D & CMO, Alkermes, Inc. | Mar 16 | Sale | 66.81 | 18,000 | 1,202,504 | 24,956 | Mar 17 05:01 PM |
| ALKS | Ehrich Elliot | SVP, R&D & CMO, Alkermes, Inc. | Feb 17 | Sale | 70.87 | 18,000 | 1,275,691 | 22,973 | Feb 18 05:19 PM |
| ALKS | Ehrich Elliot | SVP, R&D & CMO, Alkermes, Inc. | Jan 15 | Sale | 66.45 | 18,375 | 1,221,071 | 22,973 | Jan 16 05:49 PM |
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | Jun 02 | Sale | 17.80 | 1,023 | 18,209 | 18,579 | Jun 02 04:07 PM |
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | May 31 | Sale | 18.16 | 1,023 | 18,578 | 20,079 | Jun 01 04:38 PM |
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | May 27 | Sale | 18.02 | 1,450 | 26,129 | 21,579 | May 31 04:01 PM |
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | May 18 | Sale | 18.05 | 2,849 | 51,424 | 21,579 | May 19 04:40 PM |
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | May 12 | Sale | 17.00 | 5,000 | 85,000 | 21,579 | May 13 08:04 PM |
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | Nov 19 | Sale | 10.83 | 3,412 | 36,952 | 26,579 | Nov 19 05:19 PM |
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | Nov 08 | Sale | 12.02 | 341 | 4,099 | 26,579 | Nov 08 07:28 PM |
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | Sep 17 | Sale | 15.00 | 35,000 | 525,000 | 27,079 | Sep 17 05:01 PM |
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | Sep 13 | Sale | 14.07 | 5,000 | 70,350 | 32,079 | Sep 13 04:47 PM |
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | Jun 25 | Sale | 13.00 | 15,245 | 198,185 | 37,079 | Jun 29 10:05 AM |
|
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | Jun 23 | Sale | 12.32 | 3,496 | 43,071 | 37,079 | Jun 23 11:07 AM |
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | Jan 26 | Sale | 12.20 | 15,244 | 185,977 | 40,079 | Jan 27 03:30 PM |
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | Nov 06 | Sale | 7.98 | 341 | 2,721 | 40,079 | Nov 06 01:18 PM |
| ALKS | Ehrich Elliot | SVP, R&D & Chief Medical Ofcr | Jun 29 | Sale | 10.70 | 7,724 | 82,685 | 42,228 | Jun 30 01:49 PM |
